Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400137 · ClinicalTrials.gov registry record · NA
IOP Elevation Study
A NA study of Intraocular Pressure, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT03400137 is a NA study of Intraocular Pressure that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 150 participants, above the 72-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (108% higher). The trial reports 1 study location across 1 state.
The verdict
NCT03400137, a NA study of Intraocular Pressure, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is also thought that the LC is a site of primary damage during pathogenesis of the disease. This prospective study with determine the in-vivo mechanical response to IOP modulation at the level of the ONH and LC.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Increasing of intraocular pressure (IC)
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2024-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400137
The ClinicalTrials.gov registry entry for NCT03400137 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 72-participant average among 9 other Intraocular Pressure trials with a reported enrollment target (108% higher). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Intraocular Pressure appearing as the primary indexed condition, and to 1 intervention - of which Increasing of intraocular pressure (IC) is the first listed.
NCT03400137 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03400137 about?
NCT03400137 is a clinical study titled "IOP Elevation Study". The purpose of this study is to improve understanding of the pathophysiologic process that leads to the development of glaucamotous damage. The mechanism by which vision loss in glaucoma occurs is still unknown, but it is clear that increased intraocular pressure (IOP) is a major risk factor. It is ...
What is the current status of trial NCT03400137?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2018-03-07. Estimated completion is 2024-05-08.
What conditions does trial NCT03400137 study?
This clinical trial studies the following conditions: Intraocular Pressure.
What interventions are being tested in trial NCT03400137?
The interventions under investigation include: Increasing of intraocular pressure (IC) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03400137?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400137 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intraocular Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of Raised End-Tidal pCo2 on Choroidal Volume
RECRUITING · NA
-
Cutaneous Prostaglandin Application: Nail Growth, Nail Brittleness, and Eye Pressure
COMPLETED · NA
-
Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings
COMPLETED · NA
-
Effect of Position and Anesthetic Choice in Intraocular Pressure in Robotic GYN (Gynecologic) Oncology Patients
RECRUITING · Phase 4
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
-
Anterior Segment Optical Coherence Tomography Microstent Positioning
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.